Hepatectomy Clinical Trials

Clinical trials related to Hepatectomy Procedure

Application of Folic Acid-Targeted Near-Infrared-II (NIR-II) Carbon Dots in Ex Vivo Histopathological Analysis of Hepatocellular Carcinoma

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

This prospective, single-center observational study evaluates the diagnostic accuracy of a novel Folate-targeted Near-Infrared II Carbon Dot (FA-CDots) probe for the ex vivo assessment of Hepatocellular Carcinoma (HCC). Following standard radical hepatectomy, resected liver specimens will be incubated with the FA-CDots probe and imaged using a NIR-II fluorescence system. The study aims to determine the feasibility and accuracy of this technology in identifying tumor margins and micro-lesions by comparing the fluorescence imaging results with standard histopathological examination.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Primary diagnosis of Hepatocellular Carcinoma (HCC) confirmed clinically or by preoperative biopsy.

• Scheduled for radical hepatectomy.

• Preoperative imaging (CT/MRI) suggests indistinct tumor boundaries, infiltrative growth, or proximity to major vessels (expected margin \< 1cm).

• Liver function classified as Child-Pugh Grade A.

• ASA Physical Status classification I-III.

• Participant or legal guardian willing to sign informed consent for the use of ex vivo tissues.

Locations
Other Locations
China
West China Hospital
RECRUITING
Chengdu
Contact Information
Primary
Jiwei Huang Professor
huangjiwei@wchscu.cn
18980606725
Time Frame
Start Date: 2026-01-01
Estimated Completion Date: 2027-10-01
Participants
Target number of participants: 20
Treatments
Intervention group
Patients undergoing standard curative hepatectomy for HCC. Their resected tumor specimens will be used for ex vivo fluorescence imaging analysis.
Related Therapeutic Areas
Sponsors
Leads: West China Hospital

This content was sourced from clinicaltrials.gov